To our surprise, patient samples showed significantly lower expression of mature miR-17∼92 elements in BCR-ABL-positive ALL than in either BCR-ABL-negative ALL or normal CD34+ cells. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.